Sfoglia per Autore
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors
2019-01-01 Artusi C.A.; Balestrino R.; Imbalzano G.; Bortolani S.; Montanaro E.; Tuttobene S.; Fabbri M.; Zibetti M.; Lopiano L.
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease
2020-01-01 Fabbri M.; Pongmala C.; Artusi C.A.; Imbalzano G.; Romagnolo A.; Lopiano L.; Zibetti M.
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report
2020-01-01 Imbalzano, Gabriele; Artusi, Carlo Alberto; Montanaro, Elisa; Romagnolo, Alberto; Rizzone, Mario Giorgio; Lopiano, Leonardo; Zibetti, Maurizio
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis
2020-01-01 Artusi C.A.; Dwivedi A.; Romagnolo A.; Bortolani S.; Marsili L.; Imbalzano G.; Sturchio A.; Keeling E.G.; Zibetti M.; Contarino M.F.; Fasano A.; Tagliati M.; Okun M.S.; Espay A.J.; Lopiano L.; Merola A.
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential
2020-01-01 Artusi C.A.; Imbalzano G.; Sturchio A.; Pilotto A.; Montanaro E.; Padovani A.; Lopiano L.; Maetzler W.; Espay A.J.
COVID-19 in Parkinson's disease: Report on prevalence and outcome
2020-01-01 Artusi C.A.; Romagnolo A.; Imbalzano G.; Marchet A.; Zibetti M.; Rizzone M.G.; Lopiano L.
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia
2020-01-01 Fabbri M.; Zibetti M.; Calandra-Buonaura G.; Contin M.; Sambati L.; Mohamed S.; Romagnolo A.; Berchialla P.; Imbalzano G.; Giannini G.; Rizzone M.G.; Artusi C.A.; Cortelli P.; Lopiano L.
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials
2021-01-01 Merola A.; Kobayashi N.; Romagnolo A.; Wright B.A.; Artusi C.A.; Imbalzano G.; Litvan I.; Van Laar A.D.; Bankiewicz K.
Neurological comorbidities and COVID-19-related case fatality: A cohort study
2021-01-01 Romagnolo A.; Imbalzano G.; Artusi C.A.; Balestrino R.; Ledda C.; De Rosa F.G.; Riccardini F.; Montanaro E.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L.
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease
2021-01-01 Romagnolo A.; Zibetti M.; Lenzi M.; Vighetti S.; Pongmala C.; Artusi C.A.; Montanaro E.; Imbalzano G.; Rizzone M.G.; Lopiano L.
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection
2021-01-01 Piazza F.; Bozzali M.; Morana G.; Ferrero B.; Rizzone M.G.; Artusi C.A.; Parisi M.; Robert A.; Imbalzano G.; Romagnolo A.; Zibetti M.; Lopiano L.
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum
2021-01-01 Artusi, Carlo Alberto; Romagnolo, Alberto; Imbalzano, Gabriele; Montanaro, Elisa; Zibetti, Maurizio; Rizzone, Mario Giorgio; Lopiano, Leonardo
Neurological comorbidity and severity of COVID-19
2021-01-01 Romagnolo A.; Balestrino R.; Imbalzano G.; Ciccone G.; Riccardini F.; Artusi C.A.; Bozzali M.; Ferrero B.; Montalenti E.; Montanaro E.; Rizzone M.G.; Vaula G.; Zibetti M.; Lopiano L.
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease
2021-01-01 Montanaro E.; Romagnolo A.; Fabbri M.; Artusi C.A.; Imbalzano G.; Rizzone M.G.; Lopiano L.; Zibetti M.
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
2021-01-01 Artusi C.A.; Sarro L.; Imbalzano G.; Fabbri M.; Lopiano L.
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
2022-01-01 Imbalzano, Gabriele; Rinaldi, Domiziana; Calandra-Buonaura, Giovanna; Contin, Manuela; Amato, Federica; Giannini, Giulia; Sambati, Luisa; Ledda, Claudia; Romagnolo, Alberto; Olmo, Gabriella; Cortelli, Pietro; Zibetti, Maurizio; Lopiano, Leonardo; Artusi, Carlo Alberto
Time to onset and duration of botulinum toxin efficacy in movement disorders
2022-01-01 Ledda C.; Artusi C.A.; Tribolo A.; Rinaldi D.; Imbalzano G.; Lopiano L.; Zibetti M.
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease
2022-01-01 Rizzone M.G.; Mancini F.; Artusi C.A.; Balestrino R.; Bonvegna S.; Fabbri M.; Imbalzano G.; Montanaro E.; Romagnolo A.; Zibetti M.; Lopiano L.
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
2022-01-01 Montanaro E.; Artusi C.A.; Rosano C.; Boschetto C.; Imbalzano G.; Romagnolo A.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L.
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease
2022-01-01 Ledda, Claudia; Montanaro, Elisa; Imbalzano, Gabriele; Merola, Aristide; Bruno, Ilaria; Artusi, Carlo Alberto; Zibetti, Maurizio; Rizzone, Mario Giorgio; Bozzali, Marco; Sobrero, Gabriele; Vallelonga, Fabrizio; Maule, Simona; Lopiano, Leonardo; Romagnolo, Alberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors | 2019 | Artusi C.A.; Balestrino R.; Imbalzano G.; Bortolani S.; Montanaro E.; Tuttobene S.; Fabbri M.; Zibetti M.; Lopiano L. | |
| Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease | 2020 | Fabbri M.; Pongmala C.; Artusi C.A.; Imbalzano G.; Romagnolo A.; Lopiano L.; Zibetti M. | |
| Tuning Deep Brain Stimulation related depression by frequency modulation: a case report | 2020 | Imbalzano, Gabriele; Artusi, Carlo Alberto; Montanaro, Elisa; Romagnolo, Alberto; Rizzone, Mario Giorgio; Lopiano, Leonardo; Zibetti, Maurizio | |
| Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis | 2020 | Artusi C.A.; Dwivedi A.; Romagnolo A.; Bortolani S.; Marsili L.; Imbalzano G.; Sturchio A.; Keeling E.G.; Zibetti M.; Contarino M.F.; Fasano A.; Tagliati M.; Okun M.S.; Espay A.J.; Lopiano L.; Merola A. | |
| Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential | 2020 | Artusi C.A.; Imbalzano G.; Sturchio A.; Pilotto A.; Montanaro E.; Padovani A.; Lopiano L.; Maetzler W.; Espay A.J. | |
| COVID-19 in Parkinson's disease: Report on prevalence and outcome | 2020 | Artusi C.A.; Romagnolo A.; Imbalzano G.; Marchet A.; Zibetti M.; Rizzone M.G.; Lopiano L. | |
| Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia | 2020 | Fabbri M.; Zibetti M.; Calandra-Buonaura G.; Contin M.; Sambati L.; Mohamed S.; Romagnolo A.; Berchialla P.; Imbalzano G.; Giannini G.; Rizzone M.G.; Artusi C.A.; Cortelli P.; Lopiano L. | |
| Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials | 2021 | Merola A.; Kobayashi N.; Romagnolo A.; Wright B.A.; Artusi C.A.; Imbalzano G.; Litvan I.; Van Laar A.D.; Bankiewicz K. | |
| Neurological comorbidities and COVID-19-related case fatality: A cohort study | 2021 | Romagnolo A.; Imbalzano G.; Artusi C.A.; Balestrino R.; Ledda C.; De Rosa F.G.; Riccardini F.; Montanaro E.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L. | |
| Low frequency subthalamic stimulation and event-related potentials in Parkinson disease | 2021 | Romagnolo A.; Zibetti M.; Lenzi M.; Vighetti S.; Pongmala C.; Artusi C.A.; Montanaro E.; Imbalzano G.; Rizzone M.G.; Lopiano L. | |
| Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection | 2021 | Piazza F.; Bozzali M.; Morana G.; Ferrero B.; Rizzone M.G.; Artusi C.A.; Parisi M.; Robert A.; Imbalzano G.; Romagnolo A.; Zibetti M.; Lopiano L. | |
| Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum | 2021 | Artusi, Carlo Alberto; Romagnolo, Alberto; Imbalzano, Gabriele; Montanaro, Elisa; Zibetti, Maurizio; Rizzone, Mario Giorgio; Lopiano, Leonardo | |
| Neurological comorbidity and severity of COVID-19 | 2021 | Romagnolo A.; Balestrino R.; Imbalzano G.; Ciccone G.; Riccardini F.; Artusi C.A.; Bozzali M.; Ferrero B.; Montalenti E.; Montanaro E.; Rizzone M.G.; Vaula G.; Zibetti M.; Lopiano L. | |
| Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease | 2021 | Montanaro E.; Romagnolo A.; Fabbri M.; Artusi C.A.; Imbalzano G.; Rizzone M.G.; Lopiano L.; Zibetti M. | |
| Safety and efficacy of tolcapone in Parkinson’s disease: systematic review | 2021 | Artusi C.A.; Sarro L.; Imbalzano G.; Fabbri M.; Lopiano L. | |
| How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease | 2022 | Imbalzano, Gabriele; Rinaldi, Domiziana; Calandra-Buonaura, Giovanna; Contin, Manuela; Amato, Federica; Giannini, Giulia; Sambati, Luisa; Ledda, Claudia; Romagnolo, Alberto; Olmo, Gabriella; Cortelli, Pietro; Zibetti, Maurizio; Lopiano, Leonardo; Artusi, Carlo Alberto | |
| Time to onset and duration of botulinum toxin efficacy in movement disorders | 2022 | Ledda C.; Artusi C.A.; Tribolo A.; Rinaldi D.; Imbalzano G.; Lopiano L.; Zibetti M. | |
| Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease | 2022 | Rizzone M.G.; Mancini F.; Artusi C.A.; Balestrino R.; Bonvegna S.; Fabbri M.; Imbalzano G.; Montanaro E.; Romagnolo A.; Zibetti M.; Lopiano L. | |
| Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic | 2022 | Montanaro E.; Artusi C.A.; Rosano C.; Boschetto C.; Imbalzano G.; Romagnolo A.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L. | |
| Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease | 2022 | Ledda, Claudia; Montanaro, Elisa; Imbalzano, Gabriele; Merola, Aristide; Bruno, Ilaria; Artusi, Carlo Alberto; Zibetti, Maurizio; Rizzone, Mario Giorgio; Bozzali, Marco; Sobrero, Gabriele; Vallelonga, Fabrizio; Maule, Simona; Lopiano, Leonardo; Romagnolo, Alberto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile